A panel of Biotechnology & Healthcare managers discuss where they are currently finding opportunities.

Annabel Brodie-Smith, Brett Darke, Marek Poszepczynski and Geoff Hsu discuss whether Biotechnology & Healthcare is due a comeback.

Brett Darke, Marek Poszepczynski and Geoff Hsu on whether the results of the next US election will impact the Biotechnology & Healthcare sector.

Featuring comments from managers of Bellevue Healthcare Trust, International Biotechnology Trust and The Biotech Growth Trust.

In this Investment Trust Edge, we are joined by three experts who discuss HG Capital Trust, the wider private equity sector and increased merger activity in the closed-en...

In the latest Investment Trust Update, Rory Palmer discusses the enduring concerns for the BlackRock World Mining Fund, the AIC Dividends Hero list and the open letter to...

Richard Stone, Chief Executive of the Association of Investment Companies, discusses challenges with Baroness Ros Altmann, emphasizing regulatory issues leading to mislea...

David Stevenson & Annabel Brodie-Smith explore investment trusts in ISAs. Learn their importance, cut through jargon, and why patience matters in investing.

David Stevenson & Craig Baker explore Alliance Trust's strategy on The Resilient Investor, covering their multi-manager approach, stock selection, and balance for long-term success.

David Stevenson & Sam Ridley explore value investing with Joe Bauernfreund on The Resilient Investor, delving into investment trusts and strategies for new investors.